304 related articles for article (PubMed ID: 18045730)
21. The cell-penetrating peptide TAT(48-60) induces a non-lamellar phase in DMPC membranes.
Afonin S; Frey A; Bayerl S; Fischer D; Wadhwani P; Weinkauf S; Ulrich AS
Chemphyschem; 2006 Oct; 7(10):2134-42. PubMed ID: 16986196
[TBL] [Abstract][Full Text] [Related]
22. Intrinsically cell-permeable miniature proteins based on a minimal cationic PPII motif.
Daniels DS; Schepartz A
J Am Chem Soc; 2007 Nov; 129(47):14578-9. PubMed ID: 17983240
[TBL] [Abstract][Full Text] [Related]
23. Properties of cell penetrating peptides (CPPs).
Kerkis A; Hayashi MA; Yamane T; Kerkis I
IUBMB Life; 2006 Jan; 58(1):7-13. PubMed ID: 16540427
[TBL] [Abstract][Full Text] [Related]
24. Distinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cells.
Ma DX; Shi NQ; Qi XR
Int J Pharm; 2011 Oct; 419(1-2):200-8. PubMed ID: 21843610
[TBL] [Abstract][Full Text] [Related]
25. Glycosaminoglycans are required for translocation of amphipathic cell-penetrating peptides across membranes.
Pae J; Liivamägi L; Lubenets D; Arukuusk P; Langel Ü; Pooga M
Biochim Biophys Acta; 2016 Aug; 1858(8):1860-7. PubMed ID: 27117133
[TBL] [Abstract][Full Text] [Related]
26. Exogenous siRNA delivery using peptide transduction domains/cell penetrating peptides.
Meade BR; Dowdy SF
Adv Drug Deliv Rev; 2007 Mar; 59(2-3):134-40. PubMed ID: 17451840
[TBL] [Abstract][Full Text] [Related]
27. Interaction of S413-PV cell penetrating peptide with model membranes: relevance to peptide translocation across biological membranes.
Mano M; Henriques A; Paiva A; Prieto M; Gavilanes F; Simões S; de Lima MC
J Pept Sci; 2007 May; 13(5):301-13. PubMed ID: 17437249
[TBL] [Abstract][Full Text] [Related]
28. Distinct uptake routes of cell-penetrating peptide conjugates.
Lundin P; Johansson H; Guterstam P; Holm T; Hansen M; Langel U; EL Andaloussi S
Bioconjug Chem; 2008 Dec; 19(12):2535-42. PubMed ID: 19012426
[TBL] [Abstract][Full Text] [Related]
29. Ionpair-π interactions favor cell penetration of arginine/tryptophan-rich cell-penetrating peptides.
Walrant A; Bauzá A; Girardet C; Alves ID; Lecomte S; Illien F; Cardon S; Chaianantakul N; Pallerla M; Burlina F; Frontera A; Sagan S
Biochim Biophys Acta Biomembr; 2020 Feb; 1862(2):183098. PubMed ID: 31676372
[TBL] [Abstract][Full Text] [Related]
30. The cell penetrating peptides pVEC and W2-pVEC induce transformation of gel phase domains in phospholipid bilayers without affecting their integrity.
Herbig ME; Assi F; Textor M; Merkle HP
Biochemistry; 2006 Mar; 45(11):3598-609. PubMed ID: 16533042
[TBL] [Abstract][Full Text] [Related]
31. Translocation or membrane disintegration? Implication of peptide-membrane interactions in pep-1 activity.
Henriques ST; Castanho MA
J Pept Sci; 2008 Apr; 14(4):482-7. PubMed ID: 18181239
[TBL] [Abstract][Full Text] [Related]
32. Re-evaluating the role of strongly charged sequences in amphipathic cell-penetrating peptides: a fluorescence study using Pep-1.
Henriques ST; Costa J; Castanho MA
FEBS Lett; 2005 Aug; 579(20):4498-502. PubMed ID: 16083883
[TBL] [Abstract][Full Text] [Related]
33. Assessing the delivery efficacy and internalization route of cell-penetrating peptides.
El Andaloussi S; Guterstam P; Langel U
Nat Protoc; 2007; 2(8):2043-7. PubMed ID: 17703217
[TBL] [Abstract][Full Text] [Related]
34. Predicting cell-penetrating peptides.
Hansen M; Kilk K; Langel U
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):572-9. PubMed ID: 18045726
[TBL] [Abstract][Full Text] [Related]
35. Quantitatively determined uptake of cell-penetrating peptides in non-mammalian cells with an evaluation of degradation and antimicrobial effects.
Palm C; Netzereab S; Hällbrink M
Peptides; 2006 Jul; 27(7):1710-6. PubMed ID: 16500001
[TBL] [Abstract][Full Text] [Related]
36. Energy-independent translocation of cell-penetrating peptides occurs without formation of pores. A biophysical study with pep-1.
Henriques ST; Quintas A; Bagatolli LA; Homblé F; Castanho MA
Mol Membr Biol; 2007; 24(4):282-93. PubMed ID: 17520484
[TBL] [Abstract][Full Text] [Related]
37. Molecular partners for interaction and cell internalization of cell-penetrating peptides: how identical are they?
Walrant A; Bechara C; Alves ID; Sagan S
Nanomedicine (Lond); 2012 Jan; 7(1):133-43. PubMed ID: 22191782
[TBL] [Abstract][Full Text] [Related]
38. Arginine-rich cell-penetrating peptides.
Schmidt N; Mishra A; Lai GH; Wong GC
FEBS Lett; 2010 May; 584(9):1806-13. PubMed ID: 19925791
[TBL] [Abstract][Full Text] [Related]
39. Contributions of glycosaminoglycan binding and clustering to the biological uptake of the nonamphipathic cell-penetrating peptide WR9.
Ziegler A; Seelig J
Biochemistry; 2011 May; 50(21):4650-64. PubMed ID: 21491915
[TBL] [Abstract][Full Text] [Related]
40. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery.
Mäe M; Langel U
Curr Opin Pharmacol; 2006 Oct; 6(5):509-14. PubMed ID: 16860608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
